It was discovered by Idenix Pharmaceuticals and was being developed by
GlaxoSmithKline and
ViiV Healthcare, but it has now been discontinued[3][4] due to unexpected side effects.[5]
References
^Dousson C, Alexandre FR, Amador A, Bonaric S, Bot S, Caillet C, et al. (March 2016). "Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor". Journal of Medicinal Chemistry. 59 (5): 1891–8.
doi:
10.1021/acs.jmedchem.5b01430.
PMID26804933.
^"Fosdevirine". AIDSinfo. U.S. National Library of Medicine, U.S. Department of Health and Human Services. Archived from
the original on 2019-08-11. Retrieved 2018-08-14.